CervoMed Inc. Research and Development Expense
CervoMed Inc. (CRVO) reported Research and Development Expense of $4.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- CervoMed Inc. research and development expense for the quarter ending 2026-06-30 was $4.32M, a 15.40% decline year-over-year.
- CervoMed Inc. research and development expense for the quarter ending 2026-03-31 was $5.14M, a 6.15% increase year-over-year.
- CervoMed Inc. research and development expense for the quarter ending 2025-12-31 was $5.83M, a 17.73% decline year-over-year.
- CervoMed Inc. research and development expense for the quarter ending 2025-09-30 was $6.04M, a 17.86% increase year-over-year.
- CervoMed Inc. research and development expense for fiscal 2025 was $21.82M, a 16.06% increase from fiscal 2024.
- CervoMed Inc. research and development expense for fiscal 2024 was $18.80M, a 122.77% increase from fiscal 2023.
- CervoMed Inc. research and development expense for fiscal 2023 was $8.44M, a 531.40% increase from fiscal 2022.
- CervoMed Inc. research and development expense for fiscal 2022 was $1.34M, a 84.28% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.32M 10-Q · filed 2026-08-07 | $9.46M 10-Q · filed 2026-08-07 | $15.29M derived: sum of 3 quarters · filed 2026-08-07 | $21.33M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $5.14M 10-Q · filed 2026-05-15 | $10.97M derived: sum of 2 quarters · filed 2026-05-15 | $17.01M derived: sum of 3 quarters · filed 2026-05-15 | $22.11M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $11.87M derived: sum of 2 quarters · filed 2026-03-13 | $16.98M derived: sum of 3 quarters · filed 2026-08-07 | $21.82M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $6.04M 10-Q · filed 2025-11-07 | $11.15M derived: sum of 2 quarters · filed 2026-08-07 | $15.99M 10-Q · filed 2025-11-07 | $23.07M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $5.11M 10-Q · filed 2026-08-07 | $9.95M 10-Q · filed 2026-08-07 | $17.03M derived: sum of 3 quarters · filed 2026-08-07 | $22.16M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $4.84M 10-Q · filed 2026-05-15 | $11.92M derived: sum of 2 quarters · filed 2026-05-15 | $17.05M derived: sum of 3 quarters · filed 2026-05-15 | $20.82M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $12.21M derived: sum of 2 quarters · filed 2026-03-13 | $15.98M derived: sum of 3 quarters · filed 2026-03-13 | $18.80M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $5.13M 10-Q · filed 2025-11-07 | $8.90M derived: sum of 2 quarters · filed 2025-11-07 | $11.71M 10-Q · filed 2025-11-07 | $14.57M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $3.77M 10-Q · filed 2025-08-08 | $6.59M 10-Q · filed 2025-08-08 | $9.44M derived: sum of 3 quarters · filed 2025-08-08 | $11.23M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $2.81M 10-Q · filed 2025-05-12 | $5.67M derived: sum of 2 quarters · filed 2025-05-12 | $7.46M derived: sum of 3 quarters · filed 2025-05-12 | $9.42M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $4.65M derived: sum of 2 quarters · filed 2025-03-17 | $6.61M derived: sum of 3 quarters · filed 2025-03-17 | $8.44M 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | $1.79M 10-Q · filed 2024-11-12 | $3.75M derived: sum of 2 quarters · filed 2024-11-12 | $5.58M 10-Q · filed 2024-11-12 | $5.96M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.96M 10-Q · filed 2024-08-09 | $72.19K 10-Q · filed 2023-08-08 | $3.79M 10-Q · filed 2024-08-09 | $1.38M 10-Q · filed 2023-08-08 | $4.17M derived: sum of 3 quarters · filed 2024-08-09 | $4.50M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $1.83M 10-Q · filed 2024-05-14 | $1.31M 10-Q · filed 2023-05-15 | $2.21M derived: sum of 2 quarters · filed 2024-05-14 | $2.54M derived: sum of 3 quarters · filed 2024-05-14 | $4.65M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $380.69K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $711.23K derived: sum of 2 quarters · filed 2024-03-29 | $2.82M derived: sum of 3 quarters · filed 2024-03-29 | $1.34M 10-K · filed 2024-03-29 | $7.24M 10-K · filed 2023-03-24 | |||
| 2022-09-30 | $330.54K 10-Q · filed 2023-11-13 | $798.25K 10-Q · filed 2022-11-14 | $2.44M derived: sum of 2 quarters · filed 2023-11-13 | $955.78K 10-Q · filed 2023-11-13 | $5.33M 10-Q · filed 2022-11-14 | $6.37M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $2.11M 10-Q · filed 2023-08-08 | $4.53M 10-Q · filed 2023-08-08 | $6.04M derived: sum of 3 quarters · filed 2023-08-08 | $8.14M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $2.43M 10-Q · filed 2023-05-15 | $3.93M derived: sum of 2 quarters · filed 2023-05-15 | $6.04M derived: sum of 3 quarters · filed 2023-05-15 | $8.01M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $3.61M derived: sum of 2 quarters · filed 2023-03-24 | $5.58M derived: sum of 3 quarters · filed 2023-03-24 | $8.50M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $2.11M 10-Q · filed 2022-11-14 | $4.08M derived: sum of 2 quarters · filed 2022-11-14 | $6.99M 10-Q · filed 2022-11-14 | $9.58M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.97M 10-Q · filed 2022-08-12 | $4.89M 10-Q · filed 2022-08-12 | $7.47M derived: sum of 3 quarters · filed 2022-08-12 | $10.61M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.92M 10-Q · filed 2022-05-12 | $5.50M derived: sum of 2 quarters · filed 2022-05-12 | $8.64M derived: sum of 3 quarters · filed 2022-05-12 | $10.81M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $5.72M derived: sum of 2 quarters · filed 2022-03-18 | $7.89M derived: sum of 3 quarters · filed 2022-03-18 | $9.43M 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | $3.14M 10-Q · filed 2021-11-10 | $5.31M derived: sum of 2 quarters · filed 2021-11-10 | $6.85M 10-Q · filed 2021-11-10 | $8.50M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $2.17M 10-Q · filed 2021-08-11 | $3.71M 10-Q · filed 2021-08-11 | $5.37M derived: sum of 3 quarters · filed 2021-08-11 | $7.11M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $1.53M 10-Q · filed 2021-05-07 | $3.19M derived: sum of 2 quarters · filed 2021-05-07 | $4.94M derived: sum of 3 quarters · filed 2021-05-07 | $6.45M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $3.40M derived: sum of 2 quarters · filed 2021-03-17 | $4.92M derived: sum of 3 quarters · filed 2021-03-17 | $6.62M 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | $1.74M 10-Q · filed 2020-11-12 | $3.26M derived: sum of 2 quarters · filed 2020-11-12 | $4.96M 10-Q · filed 2020-11-12 | $6.33M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $1.52M 10-Q · filed 2020-08-07 | $3.22M 10-Q · filed 2020-08-07 | $4.58M derived: sum of 3 quarters · filed 2020-08-07 | $5.75M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $1.70M 10-Q · filed 2020-05-11 | $3.07M derived: sum of 2 quarters · filed 2020-05-11 | $4.24M derived: sum of 3 quarters · filed 2020-05-11 | $5.63M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $2.54M derived: sum of 2 quarters · filed 2020-03-17 | $3.93M derived: sum of 3 quarters · filed 2020-03-17 | $5.75M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $1.17M 10-Q · filed 2019-11-08 | $2.56M derived: sum of 2 quarters · filed 2019-11-08 | $4.39M 10-Q · filed 2019-11-08 | $5.53M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $1.39M 10-Q · filed 2019-08-08 | $3.22M 10-Q · filed 2019-08-08 | $4.36M derived: sum of 3 quarters · filed 2019-08-08 | $6.12M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.83M 10-Q · filed 2019-05-09 | $2.97M derived: sum of 2 quarters · filed 2019-05-09 | $4.73M derived: sum of 3 quarters · filed 2019-05-09 | $5.91M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $2.90M derived: sum of 2 quarters · filed 2019-03-19 | $4.08M derived: sum of 3 quarters · filed 2019-03-19 | $5.09M 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | $1.76M 10-Q · filed 2018-11-13 | $2.94M derived: sum of 2 quarters · filed 2018-11-13 | $3.95M 10-Q · filed 2018-11-13 | $5.46M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $1.18M 10-Q · filed 2018-08-10 | $2.19M 10-Q · filed 2018-08-10 | $3.70M derived: sum of 3 quarters · filed 2018-08-10 | $5.64M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $1.01M 10-Q · filed 2018-05-10 | $2.52M derived: sum of 2 quarters · filed 2018-05-10 | $4.46M derived: sum of 3 quarters · filed 2018-05-10 | $5.91M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $3.45M derived: sum of 2 quarters · filed 2018-04-02 | $4.90M derived: sum of 3 quarters · filed 2018-04-02 | $7.25M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $1.94M 10-Q · filed 2017-11-13 | $3.39M derived: sum of 2 quarters · filed 2017-11-13 | $5.74M 10-Q · filed 2017-11-13 | $7.01M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $1.44M 10-Q · filed 2017-08-14 | $3.80M 10-Q · filed 2017-08-14 | $5.07M derived: sum of 3 quarters · filed 2017-08-14 | $5.99M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $2.35M 10-Q · filed 2017-05-15 | $3.63M derived: sum of 2 quarters · filed 2017-05-15 | $4.55M derived: sum of 3 quarters · filed 2017-05-15 | $5.50M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.19M derived: sum of 2 quarters · filed 2017-03-31 | $3.14M derived: sum of 3 quarters · filed 2017-03-31 | $3.88M 10-K · filed 2017-03-31 | $3.85M 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $922.23K 10-Q · filed 2016-11-14 | $692.71K 10-Q · filed 2015-11-12 | $1.87M derived: sum of 2 quarters · filed 2016-11-14 | $2.60M 10-Q · filed 2016-11-14 | $3.36M 10-Q · filed 2015-11-12 | $3.75M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $948.76K 10-Q · filed 2016-08-15 | $1.12M 10-Q · filed 2015-08-12 | $1.68M 10-Q · filed 2016-08-15 | $2.67M 10-Q · filed 2015-08-12 | $2.83M derived: sum of 3 quarters · filed 2016-08-15 | $4.11M derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $731.91K 10-Q · filed 2016-05-16 | $1.55M 10-Q · filed 2015-05-11 | $1.88M derived: sum of 2 quarters · filed 2016-05-16 | $3.16M derived: sum of 3 quarters · filed 2016-05-16 | $3.42M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $2.42M derived: sum of 2 quarters · filed 2016-03-25 | $2.69M derived: sum of 3 quarters · filed 2016-03-25 | $2.86M 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | $1.27M 10-Q · filed 2015-11-12 | $930.19K 10-Q · filed 2014-11-12 | $1.54M derived: sum of 2 quarters · filed 2015-11-12 | $1.71M 10-Q · filed 2015-11-12 | $1.33M 10-Q · filed 2014-11-12 | |||
| 2014-06-30 | $266.91K 10-Q · filed 2015-08-12 | $403.41K 10-Q · filed 2014-08-14 | $436.24K 10-Q · filed 2015-08-12 | $403.41K 10-Q · filed 2014-08-14 | ||||
| 2014-03-31 | $169.33K 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | $342.92K 10-K · filed 2015-04-03 | |||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-07 | |||||||
| 2011-12-31 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |